Close Menu

NEW YORK (GenomeWeb) – Opko Health reported after the close of the markets Monday that its first quarter revenues jumped ninefold compared to Q1 2015. The company said the surge was due in large part to revenues from clinical lab Bio-Reference Laboratories, which Opko acquired in August 2015.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.